NASDAQ · OPCH

Option Care Health, Inc.

$22.43 +$0.77 (+3.55%) 1D Market open

Key Metrics

$3.40B
Market cap
16.50×
P/E · TTM
$5.67B
Revenue · TTM
$206.19M
Net income
EPS · TTM $1.24
Dividend yield
Free cash flow $212.57M
Beta · 1Y 0.19
EBITDA · TTM $347.05M
Gross margin 19.2%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 15
    From its Feb 23 high, the share price fell 46%.

    Peak close $36.09 on Feb 23; trough close $19.52 on May 15. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -46%
  • Apr 30
    The stock moved -24.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 30

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$3.40B
Enterprise value$4.38B
Shares outstanding157.0M
52-wk range$18.01 – $36.80
Avg volume · 20D1.7M
Net cash −$982.50M
Book value / share$8.10
IndustryServices-Home Health Care Services
ExchangeNASDAQ
About Option Care Health, Inc.
IPO dateAug 15, 1996
Employees8266

Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E16.50
P/S0.60
P/FCF16.00
EV/EBITDA12.63
EV/Sales0.77
Graham №$15.01

Profitability

Gross 19.2%
Operating 4.9%
Net 3.6%
FCF 3.8%
ROE / ROIC 15.0% · 8.8%

Financial Health

Current ratio1.64
Quick ratio1.07
Debt / equity0.86
Debt / EBITDA 3.34
Net cash −$982.50M
Working capital$465.36M

Cash Flow · TTM

Operating CF $253.55M
Capex −$40.98M
Free cash flow $212.57M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

3.5
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$15.01 vs $21.81
Trades 1.5× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings